Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Peripheral Arterial Disease(PAD) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

5 recruiting trials for Peripheral Arterial Disease(PAD). Eligibility criteria explained in plain English.

TrialFinderData lists 5 Peripheral Arterial Disease(PAD) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by C. R. Bard (1), Massachusetts General Hospital (1), Yonsei University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Rotarex(TM) Rotational Excisional Atherectomy System (device, 1 trial), followed by Aspirin, Clopidogrel.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
5
Sponsors

Track Peripheral Arterial Disease(PAD) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07016698

Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)

The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.

Sponsor: C. R. BardEnrolling: 6002 locations
RECRUITINGNCT07613840

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

The goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery...

Sponsor: Massachusetts General HospitalEnrolling: 4842 locations
RECRUITINGNCT02748226

Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb...

1. Study design: multicenter retrospective and prospective observational study 2. Study Cohort : 1. Retrospective cohort: This cohort retrospectively enrolls patients with...

Sponsor: Yonsei UniversityEnrolling: 120001 location
RECRUITINGNCT06631378

Transverse Versus Longitudinal Groin Incision in Vascular Surgery

The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery....

Sponsor: Kolding SygehusEnrolling: 2321 location
RECRUITINGNCT07097857

Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency...

To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention

Sponsor: Singapore General HospitalEnrolling: 151 location

Frequently Asked Questions

There are currently 5 clinical trials for Peripheral Arterial Disease(PAD), with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Peripheral Arterial Disease(PAD), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Peripheral Arterial Disease(PAD), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.